Treating IBD: Aminosalicylates Aminosalicylates are compounds that contain 5-aminosalicylic acid (5-ASA) and reduce inflammation in the lining of the intestine.
Aminosalicylate ; Mesalazine, An aminosalicylate drug used to treat mild to moderate active ulcerative colitis and also to maintain remission once achieved.
Aminosalicylates are compounds that contain 5-aminosalicylic acid (5-ASA) interactions between drugs. Drug interactions may decrease a medication's
Aminosalicylic acid is an aminosalicylate drug used to induce remission in ulcerative colitis. This data is generated by Vial. Vial is a next-generation
Aminosalicylates are anti-inflammatory drugs that contain 5-aminosalicylic acid. They are used as a first-line treatment for mild to moderate ulcerative colitis
Antimycobacterial Drugs. R.S. Vardanyan, V.J. Hruby, in Synthesis of Aminosalicylates. Aminosalicylates are the recommended first-line agents for the
This animation explains the mechanism of action of aminosalicylates used for the treatment of inflammatory bowel disease (IBD). Aminosalicylates include sulfasalazine and 5-aminosalicylic acid (5-ASA). Sulfasalazine, a sulfa drug, inhibits folic acid synthesis.
Aminosalicylates are anti-inflammatory drugs that contain 5-aminosalicylic acid. They are used as a first-line treatment for mild to moderate ulcerative colitis
4-ASA; 4-aminosalicylic acid; APAS; Amino-PAS; Aminosalicylate Sodium; P-Aminosalicylic Acid; PAS; PASK; Para-Amino Salicylic Acid; Para-aminosalicylic acid
Comments